Breaking News

Alliqua Retains INC Research

To assist with pain patch project

Alliqua, Inc. has signed an agreement with INC Research to assist with its Phase I trials for the development of its transdermal pain patch.

Richard Rosenblum, president of Alliqua, commented, “Contracting INC Research is yet another important step towards our first-in-man trial with respect to the development of our PHN pain patch. The experience that INC Research’s team brings to the table is invaluable, having been involved in development of multiple pain patch therapies on the market.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters